课题基金 / 基金详情

LEBER HEREDITARY OPTIC NEUROPATHY: GENE THERAPY

LEBER HEREDITARY OPTIC NEUROPATHY: GENE THERAPY
莱伯遗传性视神经病:基因治疗
批准号:
6384776
负责人:
John Guy
金额:
$35.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-30 至 2003-08-31

项目摘要

项目成果

John Guy的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from the applicant's abstract): Leber's hereditary optic neuropathy (LHON) is a genetic disease associated with mutations in mitochondrial DNA. The mutation has variable penetrance, but in many cases leads to severe and bilateral loss of vision in young adults. In this revision, the investigator and his senior collaborators propose to test the feasibility of delivering, expressing, and targeting normal gene products to mitochondria with the long-term objective of devising therapies for mitochondrial diseases. A recombinant adeno-associated virus (AAV) bearing a green fluorescent protein (GFP) gene and mitochondrion-specific targeting/processing signal sequences will be used to test whether proteins can be delivered safely, efficiently, and effectively into mitochondria in a cell culture system. This in vitro analysis will be followed by in vivo transduction experiments in which an attempt will be made to deliver a safe dose of a wild type NADH dehydrogenase to mitochondria in the retina and optic nerve of rats.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Intravenous MitoTargeted AAV9 Gene Therapy for Treatment of Visual Loss and Encephalopathy in Leigh Syndrome and NARP
Leber's Hereditary Optic Neuropathy: Gene Therapy Clinical Trial
Leber's Hereditary Optic Neuropathy: Gene Therapy Clinical Trial
Leber's Hereditary Optic Neuropathy: Gene Therapy Clinical Trial